ES2319968T3 - Composiciones de hierbas para el tratamiento de lesiones de la mucosa. - Google Patents

Composiciones de hierbas para el tratamiento de lesiones de la mucosa. Download PDF

Info

Publication number
ES2319968T3
ES2319968T3 ES02733198T ES02733198T ES2319968T3 ES 2319968 T3 ES2319968 T3 ES 2319968T3 ES 02733198 T ES02733198 T ES 02733198T ES 02733198 T ES02733198 T ES 02733198T ES 2319968 T3 ES2319968 T3 ES 2319968T3
Authority
ES
Spain
Prior art keywords
group
disease
extracts
mucosa
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02733198T
Other languages
English (en)
Spanish (es)
Inventor
William Z. Levine
Aron J. Saffer
Mina Faran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Herbal Synthesis Corp
Izun Pharmaceuticals Corp
Original Assignee
Herbal Synthesis Corp
Izun Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herbal Synthesis Corp, Izun Pharmaceuticals Corp filed Critical Herbal Synthesis Corp
Application granted granted Critical
Publication of ES2319968T3 publication Critical patent/ES2319968T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES02733198T 2001-05-23 2002-05-22 Composiciones de hierbas para el tratamiento de lesiones de la mucosa. Expired - Lifetime ES2319968T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL143318 2001-05-23
IL14331801A IL143318A0 (en) 2001-05-23 2001-05-23 Herbal compositions for the treatment of mucosal lesions

Publications (1)

Publication Number Publication Date
ES2319968T3 true ES2319968T3 (es) 2009-05-18

Family

ID=11075430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02733198T Expired - Lifetime ES2319968T3 (es) 2001-05-23 2002-05-22 Composiciones de hierbas para el tratamiento de lesiones de la mucosa.

Country Status (10)

Country Link
US (5) US7563466B2 (https=)
EP (1) EP1395271B1 (https=)
JP (1) JP4465155B2 (https=)
AT (1) ATE417621T1 (https=)
CA (1) CA2447180C (https=)
DE (1) DE60230407D1 (https=)
ES (1) ES2319968T3 (https=)
IL (1) IL143318A0 (https=)
PT (1) PT1395271E (https=)
WO (1) WO2002094300A1 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
IL153124A (en) 2002-11-27 2010-06-30 Herbal Synthesis Corp Solid composition that can be glued to the lining
EP1591125A1 (de) * 2004-04-19 2005-11-02 Universitätsklinikum Freiburg Pharmazeutische Zusammensetzung enthaltend Extrakte aus Flechten und Johanniskraut
BRPI0403688A (pt) * 2004-09-01 2006-05-02 Herbarium Lab Botan Ltda composto fitoterápico tópico para tratamento de herpes
CA2587565C (en) * 2004-11-22 2016-06-21 Izun Pharmaceuticals Corporation Transmucosal delivery device
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
JP5024505B2 (ja) * 2005-03-25 2012-09-12 ライオン株式会社 歯周病に起因する高脂血症改善剤、ならびに口腔用組成物及び内服薬
FR2884144B1 (fr) * 2005-04-07 2008-04-11 Eric Peltier Combinaison d'un fixateur histologique ou cytologique, et d'un ou plusieurs composes photoactivables de la famille des quinones, en particulier l'hypericine, l'hypocrelline a et l'hypocrelline b.
DE102005019653A1 (de) 2005-04-26 2006-11-02 Henkel Kgaa Pflanzenextrakte gegen Halitosis, Gingivitis oder Parodontitis
US20070071840A1 (en) * 2005-09-27 2007-03-29 Sridevi Dhanaraj Method for treatment of cartilage disorders with centella extract
US7491414B2 (en) * 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
WO2007149902A1 (en) * 2006-06-20 2007-12-27 Izun Pharmaceuticals Corporation Anti-inflammatory dissolvable film
AU2013242845B2 (en) * 2006-06-20 2015-09-03 Izun Pharmaceuticals Corporation Anti-inflammatory dissolvable film
ES2605794T3 (es) 2006-07-20 2017-03-16 Izun Pharmaceuticals Corporation Película, parche o formulación sólida adhesiva que comprende Sambucus nigra, Centella asiatica y sal de 1-alquilpiridinio para el tratamiento de tejidos mucosos
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
GB0625430D0 (en) * 2006-12-20 2007-01-31 Mars Uk Ltd Composition
KR101660246B1 (ko) * 2008-07-22 2016-09-27 이준 파마슈티컬스, 인코포레이티드 국소 항염증 조합물
US8709506B2 (en) 2010-01-11 2014-04-29 Vitro Bio Sarl Synergistic compositions for the treatment of topical viral infections
WO2011124493A1 (de) * 2010-03-29 2011-10-13 Reiner Rittinghausen Zusammensetzung enthaltend bestandteile aus sonnenhut, holunder und kamille zur behandlung von erkältungskrankheiten
IT1402018B1 (it) * 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
BR112014022694B1 (pt) * 2012-03-14 2021-03-09 Izun Pharmaceuticals Corp. método para a preparação de uma composição aquosa terapêutica, extrato de ervas e composição farmacêutica contendo o referido extrato
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
EP2792389B1 (de) * 2013-04-17 2019-09-18 Global Health Solutions AG Antivirale Pharmazeutische Zusammensetzung, enthaltend einen Extrakt von Juncus acutus.
EP3057601A4 (en) 2013-10-14 2017-06-21 Izun Pharmaceuticals Corp. Methods for treatment of m-tor inhibitor-associated stomatitis
JP6294773B2 (ja) * 2014-06-27 2018-03-14 株式会社ナールスコーポレーション 口腔粘膜疾患の予防または治療用経口製剤
RU2583885C1 (ru) * 2015-01-12 2016-05-10 Сергей Витальевич Аверьянов Мазь для лечения хейлитов
CN104758697A (zh) * 2015-04-20 2015-07-08 于风叶 治疗复发性口腔溃疡的中药散剂
BR112018071518A2 (pt) 2016-04-22 2019-02-19 Receptor Life Sciences, Inc. compostos medicinais à base de planta de ação rápida e suplementos nutricionais
ITUA20163253A1 (it) * 2016-05-09 2017-11-09 Giacomo Bruzzesi Uncaria tomentosa per uso odontoiatrico
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
CN108524625A (zh) * 2018-05-31 2018-09-14 广州聚澜健康产业研究院有限公司 一种补肾益阴胶囊及其制备方法
IT201800009621A1 (it) 2018-10-19 2020-04-19 Roberto Soldati Composizione fitoterapica ozonizzata per la rigenerazione tissutale e ossea
EP3883595A4 (en) 2018-11-19 2022-12-14 Receptor Holdings, Inc. N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID-BASED COMPOSITIONS
ES2850277B2 (es) * 2019-01-10 2025-10-15 Innovacorium Inc Composiciones de administración farmacéutica y usos de las mismas
IL302462A (en) * 2020-10-28 2023-06-01 Izun Pharmaceuticals Corp Treatment of oral mucositis
FR3124378B1 (fr) * 2021-06-24 2024-10-25 Bobs Silver Composition antiseptique pour administration nasale
US20230405044A1 (en) * 2020-11-04 2023-12-21 Bobs Silver Antiseptic composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146633A (en) * 1973-05-07 2000-11-14 The Ohio State University Method for treatment of antigenically modified polypeptides
JPS61165334A (ja) 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
US5162037A (en) * 1988-04-01 1992-11-10 Whitson Laboratories, Inc. Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
AU6208494A (en) 1993-03-02 1994-09-26 Universidad De Valladolid Non-toxic ribosome inactivating proteins (rips) with two chains, process for the preparation thereof and applications
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5977176A (en) * 1995-06-27 1999-11-02 Wise; Ronald D. Compositions for the treatment of warts and herpes
US6428819B1 (en) * 1996-12-15 2002-08-06 David Lavie Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis
US6039949A (en) * 1997-02-27 2000-03-21 Campamed, Inc. Method of preparation and composition of a water soluble extract of the plant species uncaria
KR100228873B1 (ko) 1997-03-24 1999-11-01 강재헌 센텔라아시아티카에서 분리한 아시아티코사이드와 마테카소 사이드의 수용성 추출물을 함유한 간세포 및 항간섬유화 치료제
JPH10279468A (ja) 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 皮膚外用剤
US5834000A (en) * 1997-04-11 1998-11-10 Yng-Wong; Quing Non Antiviral and antimicrobial herbal complex
FR2770776B1 (fr) 1997-11-07 2000-03-17 Lvmh Rech Utilisations du d-xylose et de ses esters pour ameliorer la fonctionnalite des cellules de l'epiderme
KR20060123663A (ko) 1999-08-27 2006-12-01 미시간 스테이트 유니버시티 천연 사이클로옥시게나제 저해물질을 함유하는 조성물
JP2001098263A (ja) 1999-09-30 2001-04-10 Fancl Corp 新規抗酸化組成物及び抗炎症組成物
EP1236466B1 (en) * 2001-02-28 2011-09-21 Axiomedic Ltd. Solid self-adhesive compositions for topical treatment of oral mucosal disorders
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US7565466B2 (en) * 2006-03-22 2009-07-21 Infineon Technologies Ag Memory including an output pointer circuit

Also Published As

Publication number Publication date
JP2004530698A (ja) 2004-10-07
CA2447180A1 (en) 2002-11-28
EP1395271A1 (en) 2004-03-10
US9855307B2 (en) 2018-01-02
ATE417621T1 (de) 2009-01-15
US7563466B2 (en) 2009-07-21
US20090186104A1 (en) 2009-07-23
CA2447180C (en) 2014-07-08
IL143318A0 (en) 2002-04-21
US20090297641A1 (en) 2009-12-03
EP1395271B1 (en) 2008-12-17
JP4465155B2 (ja) 2010-05-19
PT1395271E (pt) 2009-03-23
US20040151789A1 (en) 2004-08-05
DE60230407D1 (de) 2009-01-29
US8075926B2 (en) 2011-12-13
US20140193345A1 (en) 2014-07-10
US20110052733A1 (en) 2011-03-03
WO2002094300A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ES2319968T3 (es) Composiciones de hierbas para el tratamiento de lesiones de la mucosa.
US7943169B2 (en) Absorbable solid compositions for topical treatment of oral mucosal disorders
HUE031941T2 (en) Treatment and prevention of mucositis by anthocyanidin derivatives
KR20080016596A (ko) 의료 장치 및 의약 제형에 유용한 점액 접착성자일로글루칸 함유 제형
JP5513111B2 (ja) フィルム送達リンス
KR20140138894A (ko) 질병 치료를 위한 신규한 방법 및 조성물
IL182999A (en) Use of a support layer and a sticky reservoir in the preparation of a delivery device, a trans-mucosal delivery device and a kit for the treatment of oral diseases
Indhumathi et al. A review on medicated chewing gum and its role in mouth ulcers
Aghazadeh et al. Comparative evaluation of clinical and radiographic success of MTA and propolis in pulpotomy of primary molars
US20170020946A1 (en) Analgesic compositions and methods of use
WO2011057363A1 (en) Disposable device and uses thereof for skin and mucosal applications
Sharma Three Plants Kings of Dentistry: A Review on Aloe Vera, Allium Sativum, and Mangifera Indica
CN110859790B (zh) 中药组合物在制备口腔护理用品中的应用
Dhamai et al. Polyherbal Chewing Gum: A Comprehensive Exploration of Design and Quality for Mouth Ulcers Relief
Mali A REVIEW ON HERBAL ORAL GEL OF MULETHI (GLYCYRRHIZA GLABRA) FOR GINGIVITIS
IT202400003244A1 (it) Composizione farmaceutica e uso nel trattamento delle infezioni della cute e delle mucose
Galal et al. Therapeutic efficacy of herbal formulations for recurrent aphthous ulcer. correlation with salivary epidermal growth factor
SANJAY et al. FORMULATION AND EVALUATION OF ORAL HERBAL MEDICATED JELLY FROM GLYCYRRHIZA GLABRA AND PSIDIUM GUAJAVA LINN EXTRACT FOR TREATMENT OF MOUTH ULCER
Prajapati Investigating the Healing Effects of Guava and Jasmine Leaf BlendsOn Mouth Ulcer
Damle et al. Herbal Remedies: A Natural Approach to Managing Mouth Ulcers